SCHEMBL4019720

SCHEMBL4019720

Oc1ccc2ccccc2c1CCCc1c(O)ccc2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.70
CYP1A2 P05177 3/20 0.70
CYP2C9 P11712 2/20 0.70
CYP2C19 P33261 2/20 0.70
KDM4E B2RXH2 7/20 0.66
ALDH1A1 P00352 6/20 0.66
GAA P10253 6/20 0.66
MAPT P10636 5/20 0.66
TAAR1 Q96RJ0 1/20 0.66
TDP1 Q9NUW8 2/20 0.59
GLA P06280 1/20 0.59
HPGD P15428 1/20 0.59
PTPN22 Q9Y2R2 1/20 0.54
CRHBP P24387 1/20 0.53
CRHR2 Q13324 1/20 0.53
KMT2A Q03164 6/20 0.51
CYP2D6 P10635 2/20 0.51
HIF1A Q16665 2/20 0.51
LMNA P02545 1/20 0.51
MEN1 O00255 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8398635 0.94 HSD17B10 (0.68) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL226196 0.91 HSD17B10 (0.76) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL29227179 0.90 HSD17B10 (0.63) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL7356436 0.89 KDM4E (0.68) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL6400208 0.89 HSD17B10 (0.61) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL7366581 0.89 HSD17B10 (0.61) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL6398366 0.87 HSD17B10 (0.59) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL5898001 0.87 HSD17B10 (0.59) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL10825720 0.87 HSD17B10 (0.59) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL30873471 0.86 HSD17B10 (0.68) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320180-A1 HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT DIC CORPORATION (JP) 2025-10-16 US disclosed
US-20250277080-A1 PHENOLIC HYDROXY GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE DIC CORPORATION (JP) 2025-09-04 US disclosed
US-20250277081-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED OBJECT, AND LAMINATE DIC CORPORATION (JP) 2025-09-04 US disclosed
US-20250223396-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE DIC CORPORATION (JP) 2025-07-10 US disclosed
WO-2025105118-A1 EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND DISASSEMBLING METHOD DIC株式会社 2025-05-22 WO disclosed
WO-2025105119-A1 EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND DISASSEMBLING METHOD DIC株式会社 2025-05-22 WO disclosed
WO-2025105121-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT THEREOF, AND DISASSEMBLABLE ADHESIVE MATERIAL DIC株式会社 2025-05-22 WO disclosed
EP-4261037-B1 EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE DAINIPPON INK & CHEMICALS (JP) 2025-04-16 EP disclosed
EP-4527832-A1 HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT DIC Corporation (JP) 2025-03-26 EP disclosed
EP-4527870-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE DIC Corporation (JP) 2025-03-26 EP disclosed
US-7569654-B2 Epoxy resin composition, process for producing epoxy resin, novel epoxy resin, novel phenol resin DIC CORPORATION (JP) 2009-08-04 US disclosed
US-7456247-B2 Phenolic resin formed from a difunctional phenol and a divinyl ether DAINIPPON INK AND CHEMICALS, INC. (JP) 2008-11-25 US disclosed
US-7365147-B2 Epoxy resin composition, process for producing epoxy resin, novel epoxy resin, novel phenol resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2008-04-29 US disclosed
US-20060247392-A1 Epoxy resin composition, process for producing epoxy resin, novel epoxy resin, novel phenol resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-11-02 US disclosed
US-20060241274-A1 Epoxy resin composition, process for producing epoxy resin, novel epoxy resin, novel phenol resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-10-26 US disclosed
US-20060235183-A1 Epoxy resin composition, process for producing epoxy resin, novel epoxy resin, novel phenol resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-10-19 US disclosed
US-7087702-B2 Epoxy resin composition, process for producing epoxy resin, novel epoxy resin, novel phenol resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-08-08 US disclosed
EP-1411101-B1 Epoxy resin composition and process for producing epoxy resins DAINIPPON INK & CHEMICALS (JP) 2006-04-19 EP disclosed
US-20040087740-A1 Epoxy resin composition, process for producing epoxy resin, novel epoxy resin, novel phenol resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-05-06 US disclosed
EP-1411101-A1 Epoxy resin composition, process for producing epoxy resin, novel epoxy resin, novel phenol resin DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320180-A1 HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT RAD51, SEM1, GFER HSD17B10 495/4885CYP1A2 865/4885CYP2C9 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.